We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current A1ZN34 market cap is 115.61B. The company's latest EPS is USD 4.5371 and P/E is 26.43.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 12.02B | 12.68B | 12.94B | 13.57B | 14.89B |
| Operating Income | 1.23B | 3.1B | 2.72B | 2.09B | 2B |
| Net Income | 960M | 2.18B | 1.93B | 1.43B | 1.5B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 26.62B | 37.42B | 44.35B | 45.81B | 54.07B |
| Operating Income | 4.08B | -293M | 3.54B | 7.89B | 9.92B |
| Net Income | 3.2B | 112M | 3.29B | 5.96B | 7.04B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 101.12B | 102.29B | 104.34B | 104.92B | 104.04B |
| Total Liabilities | 61.95B | 64.79B | 64.74B | 64.12B | 63.16B |
| Total Equity | 39.17B | 37.5B | 39.6B | 40.81B | 40.87B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 66.73B | 105.36B | 96.48B | 101.12B | 104.04B |
| Total Liabilities | 51.09B | 66.08B | 59.43B | 61.95B | 63.16B |
| Total Equity | 15.64B | 39.29B | 37.06B | 39.17B | 40.87B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 10.35B | 2.49B | 5.57B | 8.95B | 11.86B |
| Investing | -4.06B | -2.41B | -5.29B | -6.8B | -7.98B |
| Financing | -6.57B | 2.03B | 806M | -3.33B | -4B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 4.8B | 5.96B | 9.81B | 10.35B | 11.86B |
| Investing | -285M | -11.06B | -2.96B | -4.06B | -7.98B |
| Financing | -2.2B | 3.65B | -6.82B | -6.57B | -4B |
| Market Cap | 115.61B |
| Price to Earnings Ratio | 26.43 |
| Price to Sales Ratio | 3.44 |
| Price to Cash Ratio | 33.88 |
| Price to Book Ratio | 4.55 |
| Dividend Yield | 1.99% |
| Shares Outstanding | 1.55B |
| Average Volume (1 week) | 409 |
| Average Volume (1 Month) | 1.51k |
| 52 Week Change | 36.78% |
| 52 Week High | 82.80 |
| 52 Week Low | 52.79 |
| Spread (Intraday) | 3.78 (4.87%) |
| Company Name | Astrazeneca plc |
| Address |
1 francis crick avenue cambridge CB2 0AA |
| Website | https://www.astrazeneca.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
